YENSA BC FOUNDATION
- Product NDC
- 72782-101
- Requested package NDC
- 72782-101-32
- 11-digit product format
- 727820101
- Labeler code
- 72782
- Product ID
- 72782-101_d6fdbcb0-37c6-d632-e053-2995a90a6545
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- YENSA LLC
- Application
- part352
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2021-01-29
- Marketing end
- 0000-00-00
- Substance
- OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 7 g/100mL; g/100mL; g/100mL
- Pharmacologic classes
- Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 72782-101 | 72782-101-32 | D | Discontinued by firm | 2026-10-12 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72782-101-32 | 72782010132 | 32 mL in 1 TUBE (72782-101-32) | 32 ml | 2021-01-29 | 0000-00-00 | No | No | Current |